Get the Stockscreener App
0.00
100.00%
-6.81
After Hours:
7.41
7.41
+
Portage Biotech Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
See More
Previous Close:
$6.81
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.86M
Revenue:
-
Net Income/Loss:
$-67.28M
P/E Ratio:
0.00
EPS:
-94.66
Net Cash Flow:
$-9.80M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$15.82
Portage Biotech Inc Stock (PRTG) Company Profile
Compare PRTG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-07-22 | Initiated | H.C. Wainwright | Buy |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-02-21 | Initiated | B. Riley Securities | Buy |
| Aug-19-21 | Initiated | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Stock (PRTG) Latest News
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event - marketscreener.com
AlphaTON Capital Exits SEC “Baby-Shelf Rules” and Files $420.69 Million Shelf Registration Statement - markets.businessinsider.com
Why Portage Biotech Inc. stock is a value investor pickTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - Newser
Will Portage Biotech Inc. stock beat EPS estimatesJuly 2025 Opening Moves & Low Risk Entry Point Guides - Newser
Can Portage Biotech Inc. stock beat market expectations this quarterPortfolio Performance Report & Intraday High Probability Alerts - BỘ NỘI VỤ
Is Portage Biotech Inc. stock overvalued by current metricsEarnings Miss & AI Enhanced Trading Alerts - BỘ NỘI VỤ
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Portage Biotech Reports Results for Fiscal Year Ended March 31, 2025 - ADVFN
AlphaTON Capital Initiates $15.3M ATM Offering - TipRanks
Portage Biotech Stock Surges On New Preclinical Data In Mesothelioma Trial: Retail Gets More Bullish - MSN
ATON launches $15.3M at-the-market ordinary share program - Stock Titan
AlphaTON Capital Clarifies Equity Line and Expands Strategic Initiatives - The Globe and Mail
Portage Biotech’s After-Hours Surge On Preclinical Tumor Trial Data Sends Retail Optimism Sky-High - MSN
Why analysts upgrade Portage Biotech Inc. stockQuarterly Growth Report & Low Drawdown Trading Strategies - newser.com
AlphaTON Bolsters Tech Leadership with New CTO to Drive AI Growth - markets.businessinsider.com
Will Portage Biotech Inc. stock outperform growth indexesTrade Exit Summary & Safe Entry Zone Identification - newser.com
How to integrate Portage Biotech Inc. into portfolio analysis tools2025 Market Outlook & Low Drawdown Momentum Trade Ideas - newser.com
Published on: 2025-11-19 21:57:05 - newser.com
Analyzing Portage Biotech Inc. with multi timeframe chartsEarnings Overview Summary & Weekly Top Stock Performers List - newser.com
How sentiment analysis helps forecast Portage Biotech Inc.Insider Selling & Weekly Top Gainers Trade List - newser.com
AlphaTON Capital (Nasdaq: ATON) Issues Shareholder Update - GlobeNewswire
Published on: 2025-11-19 04:22:07 - newser.com
Is Portage Biotech Inc. stock a dividend growth opportunityWeekly Stock Recap & Technical Buy Zone Confirmations - newser.com
What makes Portage Biotech Inc. stock attractive to growth fundsWall Street Watch & Low Risk High Reward Ideas - newser.com
Using R and stats models for Portage Biotech Inc. forecastingGDP Growth & Verified High Yield Trade Plans - newser.com
Is Portage Biotech Inc. stock entering bullish territoryQuarterly Earnings Summary & Community Consensus Stock Picks - newser.com
AlphaTON Capital Selects P2P.org as First Institutional Staking Partner for TON Treasury Operations - markets.businessinsider.com
Regression analysis insights on Portage Biotech Inc. performance2025 Dividend Review & Verified Entry Point Signals - newser.com
Momentum divergence signals in Portage Biotech Inc. chartTrade Risk Summary & Technical Pattern Alert System - newser.com
How Portage Biotech Inc. stock benefits from tech adoptionQuarterly Market Review & Stepwise Trade Execution Plans - newser.com
Published on: 2025-11-16 04:36:16 - newser.com
Published on: 2025-11-16 01:54:11 - newser.com
Is a relief rally coming for Portage Biotech Inc. holdersEarnings Miss & Community Supported Trade Ideas - newser.com
Is this a good reentry point in Portage Biotech Inc.Earnings Recap Summary & Short-Term High Return Strategies - newser.com
Portage Biotech Inc Stock (PRTG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.44%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):